SynthesisMedicine2019

Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes: A meta-analysis.

Cai-Yan Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.